Prescription drug · ANDA
Cefoxitin NDC 44567-246
Cefoxitin sodium 2 g/1 · Injection, Powder, For solution · Intravenous · WG Critical Care, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 44567-246-25 | 44567024625 | 25 VIAL in 1 CARTON (44567-246-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIALMarketed from Feb 18, 2015 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cefoxitin
- Generic name (nonproprietary)
- cefoxitin
- Active ingredients
- Cefoxitin sodium — 2 g/1
- Dosage form
- Injection, Powder, For solution
- Route
- Intravenous
- Labeler
- WG Critical Care, LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 065414
- Marketing start
- Listing expires
- Other FDA classes
- Cephalosporins (Chemical structure)
- Identifiers
- Product ID 44567-246_82954050-7b68-40e3-9fa1-0df9e1f512edSPL ID 82954050-7b68-40e3-9fa1-0df9e1f512edSPL set ID 658a0dc6-6da5-44dc-94f2-1211619297f7RxCUI 1665102, 1665107UNII Q68050H03TUPC 0344567246250
- Pharmacologic class
- Cephalosporin Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N444567024625followed by a unit qualifier and the quantityPackage 44567-0246-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Treatment Cefoxitin for Injection, USP is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. (1) Lower respiratory tract infections , including pneumonia and lung abscess, caused by Streptococcus pneumoniae, other streptococci (excluding enterococci, e.g., Enterococcus faecalis [formerly Streptococcus faecalis]), Staphylococcus aureus (including penicillinase-producing strains), Escherichia coli, Klebsiella species, Haemophilus influenzae, and Bacteroides species. (2) Urinary tract infections caused by Escherichia coli, Klebsiella species, Proteus mirabilis, Morganella morganii, …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 065414
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cefoxitin | Cefoxitin sodium 1 g/1 | Injection, Powder, For solutionIntravenous | WG Critical Care, LLC | 44567-245 |
| Cefoxitin | Cefoxitin sodium 1 g/1 | Injection, Powder, For solutionIntravenous | WG Critical Care, LLC | 44567-245 |
| Cefoxitincefoxitin sodium | Cefoxitin sodium 2 g/1 | Powder, For solutionIntravenous | Fresenius Kabi USA, LLC | 63323-342 |
| Cefoxitincefoxitin sodium | Cefoxitin sodium 1 g/1 | Powder, For solutionIntravenous | Fresenius Kabi USA, LLC | 63323-341 |
| Cefoxitincefoxitin sodium | Cefoxitin sodium 1 g/1 | Powder, For solutionIntravenous | Fresenius Kabi USA, LLC | 63323-341 |
| Cefoxitincefoxitin sodium | Cefoxitin sodium 2 g/1 | Powder, For solutionIntravenous | Fresenius Kabi USA, LLC | 63323-342 |
| Cefoxitin | Cefoxitin sodium 2 g/1 | Injection, Powder, For solutionIntravenous | Sagent Pharmaceuticals | 25021-110 |
| Cefoxitin | Cefoxitin sodium 1 g/1 | Injection, Powder, For solutionIntravenous | Sagent Pharmaceuticals | 25021-109 |